Search research articles
Contact Us
Filters
Showing results (21-30 of 395) with videos related to
Page
of 40
Sort By:
Plos One
|
November 11, 2009
A possible role for metallic ions in the carbohydrate cluster recognition displayed by a Lewis Y specific antibody
William Farrugia, Andrew M Scott, Paul A Ramsland
Experimental Hematology
|
July 29, 2017
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors
Sara Charmsaz, Andrew M Scott, Andrew W Boyd
Expert Opinion on Drug Delivery
|
March 28, 2019
Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma
Puey Ling Chia, Andrew M Scott, Thomas John
Current Urology Reports
|
February 9, 2013
Current role of PET, CT, MR for invasive bladder cancer
Nathan Lawrentschuk, Sze Ting Lee, Andrew M Scott
Biomedicines
|
February 25, 2023
Eph Receptors in Cancer
Sakshi Arora, Andrew M Scott, Peter W Janes
New Biotechnology
|
April 9, 2011
Antibodies in oncology
Vinochani Pillay, Hui K Gan, Andrew M Scott
Seminars in Nuclear Medicine
|
June 12, 2012
PET in prostate and bladder tumors
Sze Ting Lee, Nathan Lawrentschuk, Andrew M Scott
Critical Reviews in Oncogenesis
|
January 19, 2021
Sensitization of Cancers Resistant to HER2 Antibodies
Sagun Parakh, Hui K Gan, Andrew M Scott
Cancers
|
November 13, 2025
Radioligand Therapy in Cancer Management: A Global Perspective
Gaia Ninatti, Sze Ting Lee, Andrew M Scott
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
January 15, 2022
Automated processing of solid target <sup>86</sup>Y using enriched SrO powder
Thien Dinh, Harris Panopoulos, Stan Poniger, et al.
Page
of 40
Search research articles
Search
Showing results (21-30 of 395) with videos related to
Sort By:
Page
of 40
Plos One
|
November 11, 2009
A possible role for metallic ions in the carbohydrate cluster recognition displayed by a Lewis Y specific antibody
William Farrugia, Andrew M Scott, Paul A Ramsland
Experimental Hematology
|
July 29, 2017
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors
Sara Charmsaz, Andrew M Scott, Andrew W Boyd
Expert Opinion on Drug Delivery
|
March 28, 2019
Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma
Puey Ling Chia, Andrew M Scott, Thomas John
Current Urology Reports
|
February 9, 2013
Current role of PET, CT, MR for invasive bladder cancer
Nathan Lawrentschuk, Sze Ting Lee, Andrew M Scott
Biomedicines
|
February 25, 2023
Eph Receptors in Cancer
Sakshi Arora, Andrew M Scott, Peter W Janes
New Biotechnology
|
April 9, 2011
Antibodies in oncology
Vinochani Pillay, Hui K Gan, Andrew M Scott
Seminars in Nuclear Medicine
|
June 12, 2012
PET in prostate and bladder tumors
Sze Ting Lee, Nathan Lawrentschuk, Andrew M Scott
Critical Reviews in Oncogenesis
|
January 19, 2021
Sensitization of Cancers Resistant to HER2 Antibodies
Sagun Parakh, Hui K Gan, Andrew M Scott
Cancers
|
November 13, 2025
Radioligand Therapy in Cancer Management: A Global Perspective
Gaia Ninatti, Sze Ting Lee, Andrew M Scott
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
January 15, 2022
Automated processing of solid target <sup>86</sup>Y using enriched SrO powder
Thien Dinh, Harris Panopoulos, Stan Poniger, et al.
Page
of 40